Physician profile
Elda Mullaj
NPI 1821581992
$3,784.92
in general payments reported to CMS, 2019-2025
22 companies · $531 in 2025
The $531 reported for 2025 was more than what 90% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.57 · 2021: $797 · 2022: $938 · 2023: $745 · 2024: $733 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $678.52 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $449.05 | 2021-2024 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $342.49 | 2022-2024 | Xarelto |
| Amgen INC. | $305.71 | 2022-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $293.99 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $293.30 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $267.49 | 2021-2025 | Verquvo |
| Abiomed | $247.96 | 2024 | Impella |
| Abbott Laboratories | $231.23 | 2021-2022 | |
| Pfizer INC. | $151.73 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.06 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $83.26 | 2021-2025 | Camzyos |
| Medtronic, INC. | $70.14 | 2022-2023 | Cobalt Dr Mri Surescan |
| Lantheus Medical Imaging, INC. | $60.38 | 2019-2023 | Definity |
| Esperion Therapeutics, INC. | $38.84 | 2023-2024 | Nexletol |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $38.21 | 2023-2024 | Inpefa |
| Shockwave Medical, INC | $29.45 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $23.51 | 2024 | Biopharma Sol - Contract Manuf |
| Boston Scientific Corporation | $22.61 | 2023 | Ekosonic |
| Lilly USA, LLC | $19.34 | 2025 | Jardiance |
| Edwards Lifesciences Corporation | $13.70 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Genentech USA, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elda Mullaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.